Oxford Biomedica Starts Hunt For New CEO As John Dawson Intends To Retire

LONDON (dpa-AFX) - Oxford Biomedica Plc (OXB) a British gene and cell therapy company, said on Monday that after over 13 years of service, its Chief Executive Officer or CEO John Dawson, has expressed

Related Keywords

United Kingdom ,London ,City Of ,British ,Roch Doliveux ,John Dawson ,Oxford Biomedica ,Oxford Biomedica Plc ,Biomedica Plc ,Chief Executive Officer ,Oxford ,Biomedica ,Starts ,Hunt ,John ,Awson ,Ntends ,Etire ,